The Impact of Biotechnology on Developing Countries
[2023-04-03 17:46:31]
In this study, researchers at Timo Kaphengst and Lucy Smith's ecological laboratories summarized the pros and cons of increasing the percentage of genetically modified organisms (GMOs) in developing countries. The cumulative benefits and disadvantages of the countries under consideration vary widely depending on the governance structure of each country. On the other hand, GM crops can increase export earnings, but on the other hand, dependence on Western biotechnology companies in developing countries can increase and threaten local farmers, especially small farmers . In addition, genetically modified organisms are leading to a decline in biodiversity. In view of this, the authors suggest that GM crops will no longer be promoted in developing countries. This research is downloadable.
Briefing [pdf, 800 kB, English] is part of the framework contract development policy of the European Parliament. It summarizes the growing benefits and disadvantages of GM crops in developing countries.
At the briefing session, the question is "Can biotechnology achieve its vision of fighting global starvation?" How will genetically modified organisms affect the potential of farmers' income in existing agricultural structures? I forgot to mention important things: What is the impact of biotechnology on biodiversity?
In the past few years, the cultivation area of genetically modified organisms (GMO) in developing countries is increasing. In 2011, more than half of the farmland used for cultivating GM crops was found in developing countries. The total area is 160 million hectares.
GM single crops (such as soybeans and maize) are being harvested more and more for export, not mainly domestic consumption, such as staple food / host crops (sorghum, cassava, etc.) This trend leads to reliance on Western biotechnology companies and may compromise the existence of small manufacturers. In the absence of a corresponding social security system, poor harvesting may have a serious impact on local farmers. At a more basic level, only resilient and sustainable agriculture based on various crops can ensure national food security. Current support for genetically modified organisms endanger traditional crops and biodiversity as a whole
The second ethical question of social justice is the impact on developing countries' biotechnology in food and agriculture. In this respect, organizations such as the World Bank, FAO, the International Agricultural Research Council, the Rockefeller Foundation, and the international development agencies of developed countries are discussing the "green revolution" agricultural development policy. Here biotechnology is inevitably included in existing discussion. For those who support the actions of ODA, it is claimed that developing countries must adopt agricultural production techniques under the guidance of developed countries. As mentioned above, some people think that the benefits of increased food production outweigh the short-term reversal of individual farmers.
Biotechnology is part of today's scientific development. Promoting research in this field even in developed countries and some developing countries Biotechnology has great commercial potential, in particular to bring revolutionary change to the pharmaceutical industry. The emergence of many biotechnology companies around the world clearly reflects this revolution. Some of these biotechnology companies are Monsanto (USA), Genentech (USA), E Release Miscline, High Bright USA etc. In India there are many companies that succeeded in manufacturing modern biotechnology products, especially pharmaceuticals, and India companies include Pennetia Biotech Ltd., Wipro, Reliance etc.
In developing countries, intellectual property (IPR) may have a negative impact on biotechnology products or processes that produce them. As intellectual property rights are held not only by private companies but also by public institutions, it is not possible to utilize all aspects o